NR3C2 and metabolic dysfunction-associated steatotic liver disease: This extrarenal or paracrine aldosterone production may enhance localized mineralocorticoid receptor (MR) activation, particularly in the context of MASLD and hepatic fibrogenesis [11,12,13].